vaginal atrophy

Also found in: Acronyms.

vaginal atrophy

[vaj′ənəl]

a postmenopausal condition of gradually declining tissue activity in the female reproductive tract. It is caused by a cessation of follicular inhibin and estrogen secretion. This leads to decreased negative feedback on the release of follicle-stimulating hormone and luteinizing hormone by the anterior pituitary gland. Tissue effects related to estrogen deficiency include atrophy and dystrophy of the vulva and vagina, pruritus vulvae, dyspareunia, cystourethritis, ectropion, and uterovaginal prolapse.

vaginal atrophy

A condition characterised by thinning, drying, and often dyspareunia and irritation of the vagina. Vaginal atrophy most commonly occurs in menopausal and postmenopausal women, and less commonly during breast feeding or in association with reduced oestrogen production in premenopausal women.

Management
Oestrogen creams.

vaginal atrophy

Atrophic vaginitis, see there.

References in periodicals archive ?

Ospemifene is a newer oral selective estrogen receptor modulator (SERM) that is approved by the FDA for the treatment of dyspareunia caused by vaginal atrophy in post-menopausal women (Soe et al.

The Impact of Genitourinary Syndrome of Menopause On Quality of Life

One way to fend off vaginal atrophy is to have sex, another is self-pleasure.

Vaginas Need Sex Or They'll Dry Up, Doctor Says

Effect of Foeniculum vulgare (fennel) vaginal cream on vaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled trial.

Women's health update

Our study sought to determine the effects of using a vaginal estrogen cream in the treatment of vaginal atrophy in menopausal women in India.

Treatment of vaginal atrophy with vaginal estrogen cream in menopausal Indian women

The report provides a snapshot of the global therapeutic landscape of Vaginal Atrophy (Atrophic Vaginitis)

Now Available: Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H1 2016

Vaginal atrophy and the loss of lubrication and elasticity can make sexual encounters painful, depress libido and cause irritation and bleeding during exercise.

Doctors revisit guidelines for treatment of menopause

Few health care providers use Pap tests for the evaluation of vaginal atrophy.

Atrophic vaginitis: concordance and interpretation of slides in the college of American Pathologists Cervicovaginal Interlaboratory Comparison Program in Gynecologic Cytopathology

The most common cause of urinary tract infections in post-menopausal women is vaginal atrophy," explains Dr.

Probiotics can help break the cycle of recurrent urinary tract infections: in postmenopausal women, a thinning of the vaginal lining increases susceptibility to UTIs

clearance of the medicine in osteoporosis and in vulvar and vaginal atrophy.

Pfizer Inc's (New York) Fablyn, the bone drug that failed to win US approval amid safety questions, reduced the risk of breast cancer and fractures in postmenopausal women with osteoporosis, a company-sponsored study found

Vaginal atrophy is a condition in which low estrogen levels cause a woman's vagina to narrow, lose flexibility and take longer to lubricate.

Estrogen refers to a group of hormones that play an essential role in the growth and development of female sexual characteristics and the reproductive process

Very low dosages of transvaginal oestrogens in the forms of creams, tablets and rings are effective for vaginal atrophy and urinary incontinence.

Intravaginal oestrogen and progestin administration: advantages and disadvantages

REDUCED oestrogen levels after menopause lead to a thinning of the vaginal wall, known as vaginal atrophy.

vital: What's the alternative? Dee Atkinson of Napiers Herbalists gives the alternative solution